Network pharmacology of agmatine, depression and suicide-overlapping targets

Vol 1, 2023 - 169210
Trabalho
Favoritar este trabalho
Como citar esse trabalho?
Resumo

INTRODUCTION: Major depressive disorder (MDD), a mood disorder that presents high prevalence in the world population, is characterized by several symptoms such as anhedonia, depressed mood, low self-esteem and may lead to suicide behavior in more severe cases. Regarding the new therapeutic strategies that are being investigated for the treatment of MDD, agmatine (an endogenous glutamatergic modulator) stands out for producing a rapid antidepressant effect in animal models and for having synaptogenic potential similar to ketamine. Although agmatine is known to antagonize responses mediated by activation of NMDA receptors, it is possible that its antidepressant effect is dependent on its interaction with other molecular targets that may be studied through bioinformatics. Thus, this research project aims to evaluate, through bioinformatics methods, targets of agmatine relevant to its antidepressant effect.

Compartilhe suas ideias ou dúvidas com os autores!

Sabia que o maior estímulo no desenvolvimento científico e cultural é a curiosidade? Deixe seus questionamentos ou sugestões para o autor!

Faça login para interagir

Tem uma dúvida ou sugestão? Compartilhe seu feedback com os autores!

Eixo Temático
  • 10 - Neurobiologia